Orexo announces data from the MODIA® study evaluating impact on use of illicit opioids

The six-month randomized controlled trial (RCT) enrolled 437 participants at 36 sites across the US The study demonstrated no statistically significant difference between treatment arms in any pre-specified endpoint Both treatment arms had unexpectedly high rates of treatment response,…